x
Provider

new photo

Alireza Khosravi Farsani , MD

Full Professor


  Google Scholar

  Research Gate

  Orcid

  Isid

  Pubmed

  Scopus

  • Phone: 031-36115216
  • Email: alirezakhosravif@gmail.com
  • Date of birth : 00
  • CV: Dr.khosravi'S CV.pdf (1.99 MB)

School :

School of Medicine

Department :

Department of Cardiology

Research Center :

Hypertension Research Center

work address :

Hypertension Research Center, Cardiovascular Research Institute, Shahid Rahmani Alley, Moshtagh 3rd Street, Isfahan, Iran.

Education :

Professor of Cardiology Doctor of medicine (M.D), Isfahan University of medical sciences, Iran. (1985-1992) Cardiologist, Department of cardiology, Isfahan University of medical sciences. Isfahan, Iran. (1995-1999) Fellowship of Interventional Cardiology. Isfahan University of medical sciences. Isfahan, Iran. (2007-2009) Different professional educational courses in different techniques in peripheral and coronary intervention from Italy, Belgium, Germany, Frances.

Relevant Work Experience :

  Work Experience (Training Course):

  • More than 20 years experience in field of cardiology, Coronary and Non-Coronary interventions with treated thousands of patients.
  • Coronary intervention (20 years)
  • Structural and Peripheral Vascular Intervention (15 years)
  • Participating in the German Heart Center, worked with Cardiac Team and participated in structural heart cases. August 30-31, 2018, Munich. Germany.
  • Participating in the Edwards SAPIEN 3 THV Fundamentals Training. September 4-5, 2018, Edwards EMEAC Headquarters-Nyon, Switzerland.
  • Participating in learning Expert Techniques in Complex PCI Conduct. 16th and 17th of April, Clinique Pasteur, Toulouse, France, 2018.
  • Participating in the TTM Skill Training held at Charity Hospital, Berlin, Germany on November 22-23, 2016.
  • Participating in International Cardiology RX for change Curriculum: a clinical training in evidence -based treatments for tobacco use. 22 Oct 2014,Isfahan,Iran.
  • Participating in the fellow in vascular intervention Leuven belgium 2005 and 2009
  • Participating in the workshop of developed clinical trial in medical research 2003
  • Participating in the training workshop on the method of international classification of diseases ICD 10-1999.
  • Participating in the workshop on Methods of Writing and Presenting Medical Articles, 1999. 

Professional Memberships & Qualification :

  • Member of the university committee for the health promotion in mother and newborn. (2023-2025)
  • Member of Research council of Pediatric Cardiovascular Research Center. (2021- Continues)
  • Secretary / Member of the Isfahan University of medical sciences ICD Committee. (2021- Continues)
  • Member of the Heart Team of Isfahan Shahid Chamran hospital (2020- Continues)
  • Member of the Patient and Family Education Working Group (2020- Continues)
  • Member of the Committee on Economics of Treatment, Medicine and Medical Equipment (2020- Continues)
  • Member of Education Coordination Council of department of cardiology (2020- Continues)
  • Member of Emergency Committee, Patient Assignment (Bed Management) / Triage. (2020- Continues)
  • Member/Expert of the Disease Registration Committee and Health Consequences (2019- Continues)
  • Member of the Expert Panel on Cohort Design 2. (2019-continues)
  • Member of the Medical Committee of Isfahan Shahid Chamran hospital.
  • Member of the examining board and Regional evaluation of Cardiovascular Disease. (2018-2019)
  • Member of the University Committee for the Prevention and Control of Non-Communicable Diseases. (2017- continues)
  • Member of the Strategic and Policy Council of Isfahan Cardiovascular Institute (2016- continues)
  • Member of Research methods committee of Isfahan Cardiovascular Research Center. 
  • Member of Iranian Heart foundation and Iranian Heart friends.
  • Member of the Strategic Council of the Cardiology Research Network. (2011- continues)
  • Member of Research council of cardiovascular research Institute. (2013-continues)
  • Member of Research council of Isfahan cardiovascular research center (2009- Continues)
  • Member of Research council of Hypertension research center. (2011-continues)
  • Head of Research council of Hypertension research center. (2011-continues)
  • Full time Faculty member of Hypertension research center. (2011-continues)
  •  Member of Research council of Interventional Cardiology research center. (2013-continues)
  • Member of Research council of school of medicine, Isfahan University of Medical Sciences. (2013-2015)
  • Member of public council of group PhD by research of Isfahan University of Medical Sciences. (2014 – continues)
  • Member of the council of the scientific Arya Atherosclerosis journal. (2013-2014)
  • Member of technical committee of Strategic Plan for Prevention and Control of Cardiovascular Diseases comprehensive map of the province's health. (2013- continues)
  • Member of the Committee on the Treatment, Medicine and Medical Equipment of the Shahid Chamran Heart Center (2016- continues)
  • Member of the Public Health Clinical Committee (2015- continues)
  • Member of the research and educational council of the Iranian Cardiovascular Research Network (2015 – continues)
  • Member of the Board of Contracts for Promotion-Certified Cardiovascular Diseases.
  • Member of publish committee of School of Medicine.
  • Member of essential medical training programs in sections apprenticeship and heart. (2009)
  • Member organizations multicenter research databases. (2006)
  • Committee member financial evaluation of research projects Isfahan Cardiovascular Research Center.
  • Member of editorial board and consultants’ team of Research in medical science Journal (from 2008)

Extra Curricular Activities/ Interest(personal url) :

Grants & Awards :

Patents :

Presentations & Poster Sessions :

Invited Speaker/Lecture

    A: International meeting

  1. Khosravi A. " What’s New in Cath Lab? " In: Sweet Talk: Cardiometabolic & Endocrinology Forum (2-3 June), Istanbul: Turkiye,2023.
  2. Khosravi A. "PCI in complication case" In: 13th Middle East Cardiovascular Disease and 6th Congress of Clinical Cases in Complex Cardiovascular Therapeutics (21-24 October), Shiraz: Iran,2021.
  3. Khosravi A. "Diagnosis & Patient evaluation before treatment" In: 13th Middle East Cardiovascular Disease and 6th Congress of Clinical Cases in Complex Cardiovascular Therapeutics (21-24 October), Shiraz: Iran,2021.
  4. Khosravi A. "Prevention Hypertension" In: 12th Middle East Cardiovascular Disease and 5th Congress of Clinical Cases in Complex Cardiovascular Therapeutics (12 November), Shiraz: Iran,2020.
  5. Khosravi A. "Left Main Percutaneous Coronary Intervention" In: 11th Middle East Cardiovascular Congress and 4th Congress of Clinical cases in complex cardiovascular therapeutics (CCCCT4), (24-26 April), Shiraz: Iran, 2019.
  6. Khosravi A. "National implementation of cardiovascular disease registry and the role of PI’s in other provinces" In: 11th Middle East Cardiovascular Congress and 4th Congress of Clinical cases in complex cardiovascular therapeutics (CCCCT4), (24-26 April), Shiraz: Iran, 2019.
  7. Khosravi A. "Complex Cases" In: 11th Middle East Cardiovascular Congress and 4th Congress of Clinical cases in complex cardiovascular therapeutics (CCCCT4), (24-26 April), Shiraz: Iran, 2019.
  8. Khosravi A. "Latest Guidelines of Hypertension Prevention, Diagnosis and Treatment" In: 11th Middle East Cardiovascular Congress and 4th Congress of Clinical cases in complex cardiovascular therapeutics (CCCCT4), (24-26 April), Shiraz: Iran, 2019.
  9. Khosravi A. "Ascending aorta thrombosis: a rare cause of simultaneous AMI and upper limb ischemia" In: Euro PCR (21-24 May), Paris: France, 2019
  10. Khosravi A. "PCI on Left anterior descending" In: Euro PCR (21-24 May), Paris: France, 2019
  11. Khosravi A. "Closing Remarks case 16" In: Iran-Euro CTO meeting, (28 Jul), Mashhad: Iran,2017.
  12. Khosravi A. "Review of Developing the Hypertension Guideline in Iran" In: 4th International preventive Congress, (30 Sep-2 Oct), Shiraz: Iran, 2015.
  13. Khosravi A. "Definitions, Epidemiology of Hypertension" In: International Congress on Cardiac Emergencies. (ICCE). (19-21 Feb), Bandar Abbas: Iran, 2014.
  14. Khosravi A. "Cardiac rehabilitation after non-surgical interventions" In: 1st International Congress Cardiac Rehabilitation from research to practice. (21-23 October), Isfahan: Iran,2014.
  15. Khosravi A. "Review of the hypertension status and salt consumption rate in Iran" In: 2nd International Preventive Cardiology Congress (16-18 October), Shiraz: Iran,2013.
  16. Khosravi A. "Blood Pressure Epidemiology" In:  The First International Congress on Prevention, Diagnosis & Management of Hypertension. (27-29 Sep), Isfahan: Iran,2011.
  17. Khosravi A. "Salt reduction experience and strategies in Iran" In: the 13th International Symposium on Hypertension and Related Diseases. (November 3-6), Beijing: China, 2011.
  18. Khosravi A. "Developing Iranian Guidelines for Hypertension Treatment and Control" In: the13th International Symposium on Hypertension and Related Diseases. (November 3-6), Beijing: China, 2011.

B: National meeting

  1. Khosravi A. "Imaging role in angioplasty with bifurcation" In: Non-surgical invasive interventions in congenital, structural heart disease and treatment of chronic coronary heart disease, (9-11 Oct), Mashhad: Iran, 2019.
  2. Khosravi A. "Peripheral Intervention" In:3th Congress of Clinical cases in complex cardiovascular therapeutics (CCCCT3), (12-13 April), Shiraz: Iran, 2018.
  3. Khosravi A. "Multi Vessel PCI " In: Clinical Cases in Complex Cardiovascular Therapy (CCCCT2). (19-31 April), Shiraz: Iran, 2017.
  4. Khosravi A. "Endovascular aneurysm repair (EVAR) and thoracic endovascular aortic/aneurysm repair(TEVAR) " In: Clinical Cases in Complex Cardiovascular Therapy (CCCCT2). (19-31 April), Shiraz: Iran,2017.
  5. Khosravi A. "Successful Stenting of Thoracic Aortic Interruption " In: Clinical Cases in Complex Cardiovascular Therapy (CCCCT2). (19-31 April), Shiraz: Iran, 2017.
  6. Khosravi A. "Endovascular aneurysm repair(EVAR) and thoracic endovascular aortic/aneurysm repair(TEAVAR)" In: 1st Congress of Clinical cases in Complex Cardiovascular Therapeutics (CCCCT 1) (2-3 June), Shiraz: Iran, 2016.
  7. Khosravi A. "Peripheral Intervention (Iliofemoral and BTK)" In: 1st Congress of Clinical cases in Complex Cardiovascular Therapeutics (CCCCT 1). (2-3 June), Shiraz: Iran,2016.
  8. Khosravi A. "Update on Management of ST-Elevation Myocardial Infraction(STEMI) "In: The First Iranian Congress On Acute Coronary Syndromes (1st ICACS), (20-22 July), Tabriz: Iran, (2016).
  9. Khosravi A. "The interventions for lower Extremities Venous Disease symposium" In: First Symposium of peripheral vascular disease working group/Iranian Society of International Cardiology. (Jan.16), Rajaie Hospital, Tehran: Iran, 2014.

Participation/Abstract Presentation in Congresses, Seminars, Conferences:

A. International

  1. Khosravi A. Euro PCR. (16-19 May), Paris: France, 2023.
  2. Khosravi A. TOBI (Total Occlusion and Bifurcation Interventions) Congress (15-17 November), Milano: Italia,2023.
  3. Khosravi A.CTO ESSENTIALS, 14th Chronic Total Occlusion Course (19-21 October), Istanbul: Turkiye,2023.
  4. Khosravi A. 23th International Congress on Cardiovascular Updates(ICCU), (19-22 September), Tehran: Iran,2023.
  5. Khosravi A. Gulf PCR. (14-15 Dec), Dubai, United Arab Emirates, 2022.
  6. Khosravi A. Euro PCR. (17-20 May), Paris: France, 2022.
  7. Khosravi A. Gulf PCR. (15-16 Dec), Dubai, United Arab Emirates, 2021.
  8. Khosravi A. Euro PCR. (18-20 May), Paris: France, 2021.
  9. Khosravi A. Euro PCR. (21-24 May), Paris: France, 2019.
  10. Khosravi A. Euro PCR. (22-25 May), Paris: France, 2018.
  11. Khosravi A.7th Cardiovascular Updates Regional Event, (23rd of November), Park INN by Radisson Amsterdam City West: Netherlands, 2018.
  12. Khosravi A. "Hyperlipidemia management in healthy population" In: 8th Kowsar Hospital Congress. A decade updates in cardiovascular disease. (April 24-27), shiraz: Iran, 2018. (Poster Presentation)
  13. Khosravi A. EURO CTO CLUB-9th Experts” Live” Workshop (15-16 September), Berlin: Germany, 2017.
  14. Khosravi A. Euro PCR. (16-19 May), Paris: France, 2017.
  15. Khosravi A. Leipzig Interventional Course (LINC). (January 24-27), Leipzig: Germany, 2017.
  16. Khosravi A. 10th International Cardiology Seminar Focus on Complications. (Jan), Rajaie Cardiovascular Medical & Research Center, Tehran: Iran,2017.
  17. Khosravi A. 7th Kowsar Hospital Congress. A decade updates in cardiovascular disease. (April 26-29), shiraz: Iran, 2016.
  18. Khosravi A. Euro PCR. (17-20 May), Paris: France,2016.
  19. Khosravi A. Leipzig Interventional Course (LINC). (January 26-29), Leipzig: Germany, 2016.
  20. Khosravi A.ESC Congress. (27-31 August), Rome: Italy, 2016.
  21. Khosravi A, et al. "Validation of spot urine sample compared to 24hours urine collection as a biomarker for assessment of sodium intake: Isfahan salt study" In: Word Congress of Cardiology & Cardiovascular Health(WCC), (4-7June), Mexico City:  Mexico, 2016. (Abstract)
  22. Khosravi A. Merck Serono Middle East Fz-LLC. (26-28 November), Budapest: Hungary,2015.
  23. Khosravi A. The 16th CTO Club. (19-20 Jun), Nagoya: Japan,2015.
  24. Khosravi A. Euro PCR. (19-22 May), Paris: France,2015.
  25. Khosravi A. "Iranian Network of Cardiovascular Research" In: 4th International preventive Congress, (30 Sep-2 Oct), Shiraz: Iran, 2015.
  26. Khosravi A. 4th International preventive Congress, (30 Sep-2 Oct), Shiraz: Iran, 2015
  27. Khosravi A, et al. "Evaluating Factors Associated with Uncontrolled Hypertension: Isfahan Cohort Study" In: 1st International Congress Cardiac Rehabilitation from research to practice. (21-23 October), Isfahan: Iran,2014. (Poster Presentation)
  28. Khosravi A. Esc Congress, (30Aug- 3 Sep), Barcelona: Spain, 2014.
  29. Khosravi A, et al. "Comparison opinions about causes of failure medication adherence in hypertension" In: 1st International Congress Cardiac Rehabilitation from research to practice. (21-23 October), Isfahan: Iran,2014. (Poster Presentation)
  30. Khosravi A, et al. "Perspective of hospital incidence rate of deep venous coagulopathy" In:  1st International Congress Cardiac Rehabilitation from research to practice. (21-23 October), Isfahan: Iran,2014. (Poster Presentation)
  31. Khosravi A, et al. "A case of Marfan's syndrome with multi-level aortic dissections" In: 1st International Congress Cardiac Rehabilitation from research to practice. (21-23 October), Isfahan: Iran,2014. (Poster Presentation)
  32. Khosravi A. Leipzig Interventional Course (LINC). (January 28-31), Leipzig: Germany, 2014. (Abstract)
  33. Khosravi A. Euro PCR, (20-23 May), Paris: France, 2014.
  34. Khosravi A. Euro PCR, (21-24 May), Paris: France, 2013.
  35. Khosravi A. The role of community-based lifestyle intervention on salt intake and blood pressure in Iran. ESC congress, (26 August), Munich: Germany, 2012. (Poster Presentation)
  36. Khosravi A. Hypertension control in industrial impact of shimsco study in Iran. ESC congress, (27 August), Munich: Germany, 2012. (Poster Presentation)
  37. Khosravi A. "Treatment choice in hypertension: evidence versus conventional opinion", (August 25), Munich: Germany,2012.
  38. Khosravi A. Total Occlusion and Bifurcation Interventions Congress. (September 15-16), Venice Mestre: Italia, 2011.
  39. Khosravi A, et al. "Prevalence, treatment and awareness of Hypertension and its care in Isfahan " In:  The First International Congress on Prevention, Diagnosis & Management of Hypertension. (27-29 Sep), Isfahan: Iran,2011. (Oral Presentation)
  40. Khosravi A, et al. "Comparison of three methods of hope therapy, drug therapy and cognitive-behavioral therapy on the general health of patients with major hypertension" In:  The First International Congress on Prevention, Diagnosis & Management of Hypertension. (27-29 Sep), Isfahan: Iran,2011. (Oral Presentation)
  41. Khosravi A, et al. "Pulmonary artery Pressure and cardiac output effects of the arteriovenous fistula in patients with chronic renal failure" In:  The First International Congress on Prevention, Diagnosis & Management of Hypertension. (27-29 Sep), Isfahan: Iran,2011. (Poster Presentation)
  42. Khosravi A, et al. " Comparison of weight indicators and heart risk factors by gender in a sample group of Isfahan urban society" In: The First International Congress on Prevention, Diagnosis & Management of Hypertension. (27-29 Sep), Isfahan: Iran,2011 (Poster Presentation)
  43. Khosravi A, et al. " Is there the relation between Microalbuminuria and cardiovascular risk factors in Iranian General Population?" In: The First International Congress on Prevention, Diagnosis & Management of Hypertension. (27-29 Sep), Isfahan: Iran,2011 (Poster Presentation)
  44. Khosravi A, et al. " Worksite Action Plan for Controlling Hypertension in industrial Employers" In: The First International Congress on Prevention, Diagnosis & Management of Hypertension. (27-29 Sep), Isfahan: Iran,2011. (Oral Presentation)
  45. Khosravi A, et al. " Assessment of medical treatment of hypertension in Isfahan, Najafabad and Arak" In: The First International Congress on Prevention, Diagnosis & Management of Hypertension. (27-29 Sep), Isfahan: Iran,2011 (Poster Presentation)
  46. Khosravi A. Euro PCR. (17-20 May), Paris: France,2011.
  47. Khosravi A.  3th International Psychosomatic Congress. (25-27 May), Isfahan University of Medical Sciences, Isfahan: Iran,2011.
  48. Boroujeni F,Zamania b,Wirza R,Maskon O,Khosravi A, Khalilian M. An improved seed point detection algorithm for centerline tracing in coronary angiograms. In: 7th International Conference on Information Technology - New Generations, ITNG 201012 April 2010through 14 April 2010. Code 81329. Pages 352 - 3572010 Article number 5501703.
  49. Khosravi A. Euro PCR. (25-28 May), Paris: France,2010.
  50. Khosravi A. "Preprocedural C-Reactive Protein Predictive Value in Angiographic instent Restenosis after Coronary Stent Placement in Patients with Stable Angina “In: International Symposium on Atherosclerosis. (14-18 June), Boston, Massachusetts: USA,2009. (Abstract)
  51. Khosravi A. Euro PCR. (25-28 May), Paris: France,2004.

B. National

  1. Khosravi A.8th Iranian Joint Cardiovascular Congress (14-16 June), Rajaie Conference Center, Tehran: Iran,2023.
  2. Khosravi A. Joint Iranian Cardiovascular Program. Shahid Rajaie Cardiovascular Research, Treatment and Training Center, (27Feb-1March) Tehran: Iran, 2019.
  3. Khosravi A. Iran CTO & Bifurcation Meeting (5-6 Dec), Razavi Hospital Mashhad: Iran,2018.
  4. Khosravi A. Cardiovascular Congress. (29Nov-1Dec), Tehran University of Medical Sciences: Iran, 2017.
  5. Khosravi A. 4th Iranian Cardiovascular Joint Congress. (1-4 March), Tehran: Iran, (2016)
  6. National Workshop on Cardiovascular Diseases. (7Jan), Isfahan University of Medical Sciences, Isfahan: Iran,2016.
  7. Khosravi A. "Health Evidence Synthesis and Guideline Development using the Grade Approach" In: Isfahan University of Medical Sciences, (14-15 Dec), Isfahan: Iran,2016.
  8. Khosravi A.  17th Congress of Iranian Heart Association. (10-13 May0, Tehran: Iran, 2011.
  9. Khosravi A.  The second annual Conference on Interventional Cardiology. (5-6 Feb), Shaheed Rajaie Heart center, Tehran: Iran,2009.
  10. Khosravi A.  The First Regional (EMRO) Congress on Tobacco and Health, CAD morbidity in diabetic and non- diabetic group in smoker, passive smoke and non- smoker.  (28-30 Jan), Kish Island: Iran, 2009.
  11. Khosravi A. Conference on Heart and New Technologies. (28Feb-3March), Mazandaran University of Medical Sciences: Iran,2006.
  12. Khosravi A.  6th National Congress of Cardiology. (11-12 June), Mashhad: Iran, 2004.

Research Experience :

  • NCD Risk Factor Collaboration (NCD-RisC), Khosravi A. Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. Lancet, 2021 Sep 11;398(10304):957-980
  • NCD Risk Factor Collaboration (NCD-RisC), Khosravi A. Height and body-mass index trajectories of school-aged children and adolescents from 1985 to 2019 in 200 countries and territories: a pooled analysis of 2181 population-based studies with 65 million participants. Lancet 2020; 396: 1511–24.
  • NCD Risk Factor Collaboration (NCD-RisC), Khosravi A. Repositioning of the global epicenter of non-optimal cholesterol. Nature.2020 Jun;582(7810):73-77.
  • NCD Risk Factor Collaboration (NCD-RisC), Khosravi A. Heterogeneous contributions of change in population distribution of body mass index to change in obesity and underweight. eLife. Volume 10, March 2021, Article number e60060. 
  • Kelishadi, R Sharifi, Khosravi A et al. Relationship between C-reactive protein and atherosclerotic risk factors and oxidative stress markers among young person’s 10-18 years old Source: CLINICAL CHEMISTRY 2007;53(3):456-464
  • Khosravi A, Mansouri A, Shahsanayi F, Paydari N, Heshmat-Ghahdarijani K, Mansourian M, Nouri F, Taheri M, Farshidi H, Kazemi T, Khaledifar A, Assareh A, Behnammoghadam M, Peighambari M, Nematipour E, Sarrafzadegan N, Noohi F. Rationale and Design of the Persian Cardiovascular Disease Registry (PCVDR): Scale-Up of Persian Registry of Cardiovascular Disease (PROVE). Current Problems in Cardiology. 2021;46(3), Article number 100577
  • Kermani-Alghoraishi M, Pourbehi A, Kafi F*, Khosravi A**. Coronavirus disease 2019 (COVID-19) and severe pericardial effusion: from pathogenesis to management: A Case Report Based Systematic Review. Current problems in cardiology.2022 Feb;47(2):1-18.
  • Arsang-Jang S, Mansourian M, Mohammadifard N, Khosravi A, Oveis-Gharan S, Nouri F, Sarrafzadegan N. Temporal trend analysis of stroke and salt intake: a 15-year population-based study. Nutritional Neuroscience. 2021;24(5):384-394.
  • Haghighatdoost F, Atefi M, Mohammadifard N *, Daryabeygi-Khotbehsara R, Khosravi A, Mansourian M. The relationship between ultraprocessed food consumption and obesity indicators in Iranian adults. Nutrition, Metabolism & Cardiovascular Diseases.2022;32(9):2074-2085.
  • Rahimlou M, Grau N, Banaie –Jahromi N, Taheri M, Khosravi A, Mavrommatis Y, Mohammadifard N*. Association of adherence to the dietary approach to stop hypertension and Mediterranean diets with blood pressure in a non-hypertensive population: Results from Isfahan Salt Study (ISS). Nutrition, Metabolism & Cardiovascular Diseases. 2022 Jan;32(1):109-116.
  • Arsang-Jang S, Mansourian M, Mohammadifard N, Khosravi A, Oveis-Gharan S, Nouri F, Sarrafzadegan N. Temporal trend analysis of stroke and salt intake: a 15-year population-based study. Nutr Neurosci. 2019 Sep 13:1-11. doi: 10.1080/1028415X.2019.1638665. [Epub ahead of print]
  • Kelishadi R, Sadri G, Tavasoli A, Kahbazi M, Roohafza H, Sadeghi M,  Khosravi A, Sabet B, Amani A, Ansari R, Alikhasi H. Cumulative prevalence of risk factors for atherosclerotic cardiovascular diseases in Iranian adolescents: IHHP-HHPC. J Pediatr (Rio J). 2005 Nov-Dec; 81(6):447-53.
  • Sarrafzadegan, N, Rabiei, K, Kabir A, Khosravi A, et al. Changes In Lipid Profile Of Patients Referred To A Cardiac Rehabilitation Program Source: European Journal Of Cardiovascular Prevention & Rehabilitation 2008; 15(4):467-472.
  •  Mohammadifard N,  Grau N,  Khosravi A,  Esmaillzadeh A ,  Feizi A ,  Abdollahi Z ,  Sarrafzadegan N*.Validation and reproducibility of a semiqualitative food frequency questionnaire for assessment of sodium intake in Iranian population. Nutrition Journal. 2022 Feb 4;21(1):1-12.
  • Mohammadifard N, Marateb H, Mansourian M, Khosravi A, Abdollahi Z, Campbell R, Webster J, Petersen K, Sarrafzadegan N. Can methods based on spot urine samples be used to estimate average population 24 h sodium excretion? Results from the Isfahan Salt Study. Public Health Nutrition. 2020 Feb;23(2):202-213.
  • Sarrafzadegan N, Kelishadi R, Dana Siadat Z, Esmaillzadeh A, Solhpour A, Shirani S, Naderi G, Asgary S, Sadri G, Khosravi A, Bahonar A. Obesity and cardiometabolic risk factors in a representative population of Iranian adolescents and adults in comparison to a Western population: The Isfahan Healthy Heart Programme. Public Health Nutr. 2010, 13(3), 314–323.
  • Khosravi A, Mansouri A,  Shahsanayi F, Paydari N, Heshmat-Ghahdarijani K, Mansourian M, Nouri F, Taheri M, Farshidi H, Kazemi T, Khaledifar A, Assareh A, Behnammoghadam M, Peighambari M, Nematipour E, Sarrafzadegan N, Noohi F.
    Rationale and Design of the Persian Cardiovascular Disease Registry (PCVDR): Scale-Up of Persian Registry of Cardiovascular Disease (PROVE). Current Problems in Cardiology. Available online 12 March 2020, In Press, Corrected Proof.
  • Gharipour M, Kelishadi R, Khosravi A, Shirani Sh, Masjedi M, Sarrafzadegan N. The impact of a community trial on the pharmacological treatment in the individuals with the metabolic syndrome: findings from the Isfahan Healthy Heart Program, 2001-2007. Arch Med Sci, 2012; 8(6):1009-1017
  • Khosravi A, Kelishadi R, Pourmoghaddas M, Shirani S, Asgari S,Khosravi M. Preprocedural C-reactive protein predictive value in angiographic in-stent restenosis after coronary stent placement in patients with stable angina . ARCHIVES OF MEDICAL SCIENCE 2009;5(2):166-171.
  • Oveisgharan S, Sarrafzadegan N, Shirani S, Khosravi A, et al. Stroke in Isfahan, Iran: hospital admission and 28-day case fatality rate: CEREBROVASCULAR DISEASES 2007: 24(6):495-499.
  • Sadeghipour P, Talasaz A, Eslami V, Gerayeli B, Vojdanparast M, Sedaghat M, Fakhr Moosavi A, Alipour Parsa S, Aminian B, Firouzi A, Ghafari S, Ghasemi M, Kazemi Saleh D, Khosravi A, Kojuri J, Noohi F, Pourhosseini H, Salarifard M, Salehi M, Sezavar H, Shabestari M, Soleimani A, Tabarsi P, Zand Parsa A, Abdi s. Management of ST-segment-elevation myocardial infarction during the coronavirus disease 2019 (COVID-1 9) outbreak: Iranian “247” National Committee's position paper on primary percutaneous coronary intervention. Catheterization and cardiovascular interventions.  2021,97(3):346-351.
  •  Gholami A , Ghanbari A ,  Rezaei Sh,  Baradaran H ,  Khatibzadeh S,  Parsaeian M ,  Hariri M,  Zamaninour N,  Sheidaei A,  Abdollahi M ,  Mirmiran P ,  Ghayour-Mobarhan M,  Ostovar A, Mohammadifard N ,  Khosravi A,  Namayandeh M,  Farzadfar F *.National and sub-national trends of salt intake in Iranians from 2000 to 2016: a systematic analysis. Arch Public Health.2022 Apr 13;80(1):120.
  • Eghbali M, Akbari M, Seify K,Fakhrolmobasheri M,Heidarpour M ,Roohafza H,  Afzali M ,Mostafavi-Esfahani F ,Karimian P ,Sepehr A,Shafie D* ,Khosravi A. Evaluation of Psychological Distress, Self-Care, and Medication Adherence in Association with Hypertension Control. International journal of hypertension. Volume 2022 | Article ID 7802792.
  • Soltani S, Saraf-Bank S, Basirat R, Salehi-Abargouei A, Mohammadifard N, Sadeghi M, Khosravi A, Fadhil I, Puska P, Sarrafzadegan N. Community-based cardiovascular disease prevention programmes and cardiovascular risk factors: a systematic review and meta-analysis. Public Health. 2021 Nov; 200:59-70.
  • Kelishadi R, Mokhtari M, Tavasoli A, Khosravi A, Ahangar-Nazari I, Sabet B, Kazemi A, Amini A. Determinants of tobacco use among youths in Isfahan, Iran. Int J Public Health. 2007; 52(3):173-9.
  • Khosravi A, Gharipour M, Nezafati P, Khosravi Z, Sadeghi M7, Khaledifar A, Taheri M, Golshahi J, Sarrafzadegan N. Pre-hypertension, pre-diabetes or both: which is best at predicting cardiovascular events in the long term? Journal of Human Hypertension, 2017; 31(6):382-387.
  • Khosravi A,Kiani mehr G,Kelishadi R,Shirani S,Gharipour M,Tavassoli A,Nouri F, Sarrafzadegan N.The impact of a 6-year comprehensive community trial on the awareness,treatment and control rates of hypertension in Iran:Experiences from the Isfahan healthy heart program. BMC cardiovascular disorders.2010;1-8.
  • khosravi A, Mirdamadi A, Movahed MR. Successful Retrieval of Embolized Atrial Septal Defect Occluder and Patent Foramen Ovale Closure Device Using Novel Coronary Wire Trap Technique. Catheterization and Cardiovascular Interventions 2018; 92(1):189-192.
  • Sarrafzadegan N,Bagherikholenjani F,Noohi F ,Alikhasi H ,Mohammadifard N, Ghaffari S ,Adel M,Assareh A, Zibaee Nezhad M,Tabandeh M ,Farshidi H,Khosravi A,Nematipour E,Kermani-Alghoraishi M, Hassannejad R ,Sadeghi M, Najafian J,Shafie D,Shabestari M,Mansouri A,Roohafza H, Shahidi Sh ,Yarmohammadian M ,Moeeni M. Priority setting in cardiovascular research in Iran using standard indigenous methods. Journal of Research in Medical Sciences.2022Dec 23;27:91. doi: 10.4103/jrms.jrms_343_22.
  • Tavassoli A, Gharipour M, Khosravi A, Kelishadi R, Dana Siadat Z, Bahonar A, Sadri G, Sadeghi M, Rabiei K, Sajadi F, Zarfeshani S, Eshrati B, Shirani S, Sarrafzadegan N. Gender Differences in Obesogenic Behavior, Socioeconomic and Metabolic Factors in a Population-based Sample of Iranians: The IHHP Study, J Health Popul Nutr 2010 Dec;28(6):602-609.
  • Sarrafzadegan N, Gharipour M, Sadeghi M, Nezafati P, Talaie M,Oveisgharan S,Nouri F, khosravi A.Metabolic Syndrome and the risk of Ischemic Stroke.J Stroke Cerebrovasc Dis, Feb 2017;26(2):286-294.
  • Mohammadifard N, Karimi G, Khosravi A, Sarrafzadegan N, Jozan M, Zahed P, Haghighatdoost F.High dietary acid load score is not associated with the risk of metabolic syndrome in Iranian adults.  International Journal for Vitamin and Nutrition Research. 2021;91(1-2):152-163.
  • Khosravi A, Behjati M, Mansouri A, Jozan M, Mohammadifard N, Taheri M,
    Khodarahmi S, Ansari R, Mansouri MH, Mansouri P*, Sarrafzadegan N. Evaluation of correlation between digital vs. mercury sphygmomanometer in a middle-income country: The role of socio-economic situation. Clinical and Experimental Hypertension.2022;44(2):113-118. 
  • Mohammadi-Dolatabadi A, Vakhshoori M, Eghbali-Babadi M, Heidarpour M, Shafie D, Garakyaraghi M, Khosravi A. Comparison of multiple blood pressure frequency methods with optimum blood pressure measurement among Iranian individuals. Journal of Research in Medical Sciences.2020;1(40):1-6.
  • Gharipour M, Ramezani M,Sadeghi M,Khosravi A,Masjedi M,Khosravi-Boroujeni H, Rafieian‑kopaei M,Sarrafzadegan N.Sex based levels of C‑reactive protein and white blood cell count in subjects with metabolic syndrome: Isfahan Healthy Heart Program. Journal of Research in Medical Sciences,2013;18:467-72.
  • Mohammadifard N, Haghighatdoost F, Nouri F, Khosravi A, Sarrafzadegan N. Is urinary sodium excretion related to anthropometric indicators of adiposity in adults? Journal of Research in Medical Sciences.2020;1(25):1-9.
  • Khosravi A, Kelishadi R, Sarrafzadegan N, Boshtam M, Nouri F, Zarfeshani S, Esmailzadeh A. Impact of a community-based lifestyle intervention program on blood pressure and salt intake of normotensive adult population in a developing country. J Res Med Sci 2012; 17(3):235-241.
  • Shemirani H, Hemmati R, Khosravi A, Gharipour M, M Jozan. Echocardiographic assessment of inappropriate left ventricular mass and left ventricular hypertrophy in patients with diastolic dysfunction. J Res Med Sci, 2012; 17(2); 133-137.
  • Tavassoli A, Gharipour M, Toghianifar N, Sarrafzadegan N, khosravi A, Zolfaghari B, Zarfeshani S. The impact of obesity on hypertension and diabetes control following healthy Lifestyle Intervention Program in a developing country setting. JRMS 2011; 16(Special Issue): 368-376.
  • Sarrafzadegan N,Gharipour M,Ramezani M,Rabiei K,Zolfaghari B,Tavassoli A,Boshtam M,Zarfeshani S, Khosravi A,yousefi A. Metabolic syndrome and health-related quality of life in Iranian population.journal of research in medical sciences.2011;16(3):254-261.
  • Khosravi A, Pourmoghaddas M, Ostovan M, Kiani Mehr G, Gharipour M, Zakeri H, Soleimani B, Namdari M, Hassanzadeh M, Tavassoli A, Ghaffari S, Khaledifar A, Roghani F, Khosravi M, Sarami S, Kojouri J, Nouri F, Khosravi E, Jozan M, Sarrafzadegan N. The impact of generic form of Clopidogrel on cardiovascular events in patients with coronary artery stent: results of the OPCES study. JRMS 2011; 16(5): 640-650.
  • Mohammadifard N, Khaledifar A,  khosravi A, Nouri F, Pourmoghadas A, Feizi A, Esmailzadeh A, Sarrafzadegan N. Dietary sodium and potassium intake and their association with blood pressure in a non-hypertensive Iranian adult population: Isfahan salt study. Nutrition & Dietetics. 2017; 74(3):275-282. 
  • Khosravi A, Kermani M, Pourmoghadas M. Ascending Aorta Thrombose: A Rare Cause of Simultaneous Acute Myocardial Infarction and Upper Limb Ischemia. Acta Cardiol Sinica.2020 Jul;36(4):382-385.
  • Mohammadifard N, Mahdavi A, Khosravi A, Esmaillzadeh A, Feizi A, Saarfzadegan N. Salt intake and its sources in children, adolescents and adults in Isfahan, Islamic Republic of Iran. Eastern Mediterranean Health Journal. 2021 Mar 23;27(3):279-286.
  • Roghani-Dehkordi F, Farazandeh F, Kermani-Alghoraishi M*, Khosravi A. Comparison of pain severity, satisfaction, and complications of proximal and distal forearm anesthesia in patients undergoing trans-palmar coronary angiography. Anatolian journal of cardiology. 2022; 26(1): 37-42.
  • Kelishadi R,Derakhshan R,Sabet B,Sarrafzadegan N,Kahbazi M, Sadri G.H ,Tavasoli A.A,hHeidari A,khosravi A, Amani A, Tolouei HR, Bahonar A,Rezaei Ashtiani AA,Moatarian A. The metabolic syndrome in hypertensive and normotensive subjects:the Isfahan healthy heart program. Annals Academy of Medicine,2005,34(3):243-9
  • Kelishadi R, Sarrafzadegan N, Sadri G, Pashmi R, Mohammadifard N, Tavasoli A, Amani A, Rabiei K, Khosravi A, Bahonar A .Short-Term Results of a Community-Based Program on Promoting Healthy Lifestyle for Prevention and Control of Chronic Diseases in a Developing Country Setting: Isfahan Healthy Heart Program. Asia Pac J Public Health. 2011:23(4),518-533.
  • Beigi A,Sadeghi A.M, Khosravi A,Karami M,Masoudpour H.Effects of the arteriovenous fistula on pulmonary artery pressure and cardiac output in patients with chronic renal failure.journal of vascular access.2009;10(3).160.
  • Khosravi A, Ramezani M,Toghianifar N, Rabiei K, Jahandideh M, Yousofi A. Association between Hypertension and quality of life in a sample of Iranian adults. ACTA Cardiol, Aug2010:65(4);425-430.
  • Sarrafzadegan N, Rabiei K, Kabir A, Sadeghi M, Khosravi A, Asgari S, Taghipour HR, Roohafza H. Gender differences in risk factors and outcomes after cardiac rehabilitation. Acta Cardiol. 2008 Dec; 63(6):763-70.
  • Etemadifar S, Bahrami M,Shahriari M, Khosravi A. Family Caregivers’ Experiences of Caring for Patients With Heart Failure: A Descriptive, Exploratory Qualitative Study. Journal of Nursing Research, 2015:23(2):153-161. 
  • Mohammadifard N, khosravi A, Esmailzadeh A,Feizi A, Abdollahi Z, Salehi F, Sarrafzadegan N. Rationale, design and Initial Findings: Validation of simplified tools for Assessment of sodium intake in Iranian population. Archives of Iranian Medicine. September 2016;19(9):652-658. 
  • Haghighatdoost F, Sarrafzadegan N,Khosravi A,Noori F,Boshtam M,Mohammadifard N,Abdollhi Z,Azadbakht L.Is the association between salt intake and blood pressure mediated by body mass index and central adiposity?. Archives of Iranian medicine.2013;16(3):167. 
  • Mohammadifard N, Fahimi S, Khosravi A, Pouraram H, Sajedinejad S, Pharoah P, Malekzadeh R, Sarrafzadegan N, Advocacy Strategies and Action Plans for Reducing Salt Intake in Iran. Archives of Iranian Medicine, 2012; 15(5): 320 – 324. 
  • Mohammadifard N, Karimi G, Khosravi A, Sarrafzadegan N, Jozan M, Zahed P, Haghighatdoost F.High dietary acid load score is not associated with the risk of metabolic syndrome in Iranian adults. Int J Vitam Nutr Res. 2020 Feb 5:1-12. doi: 10.1024/0300-9831/a000626. [Epub ahead of print]
  • Khosravi A, Mohammadifard N, Gharipour M, Abdollahi Z, Nouri F, Feizi A, Jozan M, Sarrafzadegan N. Low correlation between morning spot and 24-hour urine samples for estimating sodium intake in an Iranian population: Isfahan Salt Study. Int J Vitam Nutr Res. 2019 Mar 19:1-7. doi: 10.1024/0300-9831/a000558.
  • Khosravi A, Raoufi A, Pourmoghadas M, Paydari N, Gharipour M, Namdari M, Khaledifar A, Khosravi M, Bahonar A, Ostovan M, Hasanzadeh M, Sarrafzadegan N. Late clinical events of drug eluting versus bare metal stenting; OPCES’ ancillary study. Pak J Med Sci, 2013; 29(1):258-263.
  • Khosravi A Toghianifar N, Sarrafzadegan N, Gharipour M, Azadbakht L. Salt intake, obesity, and pre-hypertension among Iranian adults: A cross-sectional study. Pak J Med Sci, 2012; 28(2):297-302 
  • Shirani S, Kelishadi R, Sarrafzadegan N, Khosravi A, Sadri G, Amani A, Heidari S, Ramezani M. Awareness, treatment and control of hypertension, dyslipedemia and diabetes mellitus in an Iranian population: the IHHP study. East Mediterr Health J, Nov-Dec2009, 15(6);1455-63.
  • Shahrokhi S, Kelishadi R, Sarrafzadegan N, Khosravi A, Roohafza H, Pooya A, Mollabashi R. Evaluation of the Quit and Win contest for smoking cessation in the Islamic Republic of Iran. East Mediterr Health J. Dec 2008, 14(6):1270-9.
  • Najafian J, Toghianifar N,Khosravi A.Exertional abdominal pain as a symptom of secondary pulmonary hypertension in mitral stenosis. Nigerian journal of clinical practice.2013;16(1):110.
  • Eghbali M, Feizi A, Khosravi A, Sarrafzadegan N. The Effect of Training on Knowledge, Attitude, and Practice in Patients with Hypertension; the Application of the Expanded Chronic Care Model: A Clinical Trial Study. Iranian Red Crescent Medical Journal. May 2018;20(5): DOI: 10.5812/ircmj.61693.
  • Khosravi A,Pourmoghaddas M,Kelishadi R,Sabet B,Ansari R,Shirani SH,Sarraf zadegan N. Trends in blood pressure level, prevalence of hypertension and its care in Isfahan. IRCMJ-Iranian Red Crescent Medical Journal , 2005,8(2):62-68.
  • Gharipour M, Kelishadi R, Toghianifar N, Tavassoli A, Khosravi A, Sajadi F, Sarrafzadegan N. Socioeconomic Disparities and Smoking Habits in Metabolic Syndrome: Evidence from Isfahan Healthy Heart Program. Iran Red Crescent Med J.2011; 13(8):537-543.
  • Rajabizadeh G, Ramezani M, Roohafza H, Pourdamghan N, Khosravi A, Rabiei K, Sarrafzadegan N, Toghianifar N, Zarfeshani S. Association between cigarette smoking and socio-demographics, lifestyle and mental health factors in a sampled Iranian population. Southeast Asian J TropMed Public Health 2011, 42(4):977-87.

Research Interests :

Interventional Cardiology, Cardiovascular disease, Prevention, Control and Treatment of Hypertension

Teaching Experience :

Teaching Interests :